Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: A matched case control study
Open Access
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Médecins Sans Frontières
This publication has 21 references indexed in Scilit:
- Seroefficacy of Vi Polysaccharide–Tetanus Toxoid Typhoid Conjugate Vaccine (Typbar TCV)Clinical Infectious Diseases, 2018
- Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trialThe Lancet, 2017
- A cross-sectional seroepidemiological survey of typhoid fever in FijiPLOS Neglected Tropical Diseases, 2017
- Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance studyThe Lancet Global Health, 2017
- Systematic review of the global epidemiology, clinical and laboratory profile of enteric feverJournal of Global Health, 2015
- Typhoid feverThe Lancet, 2015
- Descriptive Epidemiology of Typhoid Fever during an Epidemic in Harare, Zimbabwe, 2012PLOS ONE, 2014
- Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustmentThe Lancet Global Health, 2014
- Population-Based Incidence of Typhoid Fever in an Urban Informal Settlement and a Rural Area in Kenya: Implications for Typhoid Vaccine Use in AfricaPLOS ONE, 2012
- The Efficacy of aSalmonella typhiVi Conjugate Vaccine in Two-to-Five-Year-Old ChildrenNew England Journal of Medicine, 2001